Advertisement
New Zealand markets closed
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NZD/USD

    0.5953
    +0.0004 (+0.06%)
     
  • NZD/EUR

    0.5547
    +0.0006 (+0.11%)
     
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • OIL

    84.12
    +0.55 (+0.66%)
     
  • GOLD

    2,358.40
    +15.90 (+0.68%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,120.38
    +41.52 (+0.51%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    18,060.74
    +143.46 (+0.80%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • NZD/JPY

    93.2500
    +0.7540 (+0.82%)
     

2 Struggling Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague

2 Struggling Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague

Teladoc Health (NYSE: TDOC) sank 74% last year -- and for one particular reason. The telemedicine giant reported two billion-dollar noncash goodwill impairment charges. Both were linked to the acquisition of chronic-care specialist Livongo.